Cargando…
Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy
Background: Pneumonectomy is a drastic but sometimes inevitable treatment option for patients with non-small-cell lung cancer (NSCLC) to improve their chances for long-term survival. However, the optimal adjuvant radiotherapy used for patients with N2 NSCLC following pneumonectomy remains unclear in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738364/ https://www.ncbi.nlm.nih.gov/pubmed/36498762 http://dx.doi.org/10.3390/jcm11237188 |
_version_ | 1784847522960769024 |
---|---|
author | Qu, Chenghao Li, Rongyang Han, Jingyi Yue, Weiming Tian, Hui |
author_facet | Qu, Chenghao Li, Rongyang Han, Jingyi Yue, Weiming Tian, Hui |
author_sort | Qu, Chenghao |
collection | PubMed |
description | Background: Pneumonectomy is a drastic but sometimes inevitable treatment option for patients with non-small-cell lung cancer (NSCLC) to improve their chances for long-term survival. However, the optimal adjuvant radiotherapy used for patients with N2 NSCLC following pneumonectomy remains unclear in the literature. Methods: T1-4N0-2M0 NSCLC patients registered in the Surveillance, Epidemiology, and End Results database were retrospectively analyzed. Propensity score matching was applied to balance the assignment of patients. Cox proportional hazards models and Kaplan–Meier analyses were used to identify the factors related to overall survival rates. Restricted cubic splines were used to detect the possible nonlinear dependency of the relationship between the risk of survival and age. Results: A total of 4308 NSCLC patients were enrolled in this study. In N2 patients, the long-term outcome of the chemotherapy and postoperative radiotherapy groups was the worst (p = 0.014). Subgroup analyses showed that the influence of age on survival outcome was confined to patients who received chemotherapy and neoadjuvant radiotherapy (p = 0.004). Meanwhile, patients >65 years of age who received chemotherapy and neoadjuvant radiotherapy had significantly worse prognoses than those in the chemotherapy group (p = 0.005). Conclusions: Our results show that neoadjuvant radiotherapy may have potential benefits in patients aged ≤ 65 years who are scheduled for pneumonectomy, but not in elderly patients. |
format | Online Article Text |
id | pubmed-9738364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97383642022-12-11 Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy Qu, Chenghao Li, Rongyang Han, Jingyi Yue, Weiming Tian, Hui J Clin Med Article Background: Pneumonectomy is a drastic but sometimes inevitable treatment option for patients with non-small-cell lung cancer (NSCLC) to improve their chances for long-term survival. However, the optimal adjuvant radiotherapy used for patients with N2 NSCLC following pneumonectomy remains unclear in the literature. Methods: T1-4N0-2M0 NSCLC patients registered in the Surveillance, Epidemiology, and End Results database were retrospectively analyzed. Propensity score matching was applied to balance the assignment of patients. Cox proportional hazards models and Kaplan–Meier analyses were used to identify the factors related to overall survival rates. Restricted cubic splines were used to detect the possible nonlinear dependency of the relationship between the risk of survival and age. Results: A total of 4308 NSCLC patients were enrolled in this study. In N2 patients, the long-term outcome of the chemotherapy and postoperative radiotherapy groups was the worst (p = 0.014). Subgroup analyses showed that the influence of age on survival outcome was confined to patients who received chemotherapy and neoadjuvant radiotherapy (p = 0.004). Meanwhile, patients >65 years of age who received chemotherapy and neoadjuvant radiotherapy had significantly worse prognoses than those in the chemotherapy group (p = 0.005). Conclusions: Our results show that neoadjuvant radiotherapy may have potential benefits in patients aged ≤ 65 years who are scheduled for pneumonectomy, but not in elderly patients. MDPI 2022-12-02 /pmc/articles/PMC9738364/ /pubmed/36498762 http://dx.doi.org/10.3390/jcm11237188 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Qu, Chenghao Li, Rongyang Han, Jingyi Yue, Weiming Tian, Hui Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title | Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title_full | Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title_fullStr | Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title_full_unstemmed | Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title_short | Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy |
title_sort | effects of neoadjuvant radiotherapy on survival in patients with stage iiia-n2 non-small-cell lung cancer following pneumonectomy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738364/ https://www.ncbi.nlm.nih.gov/pubmed/36498762 http://dx.doi.org/10.3390/jcm11237188 |
work_keys_str_mv | AT quchenghao effectsofneoadjuvantradiotherapyonsurvivalinpatientswithstageiiian2nonsmallcelllungcancerfollowingpneumonectomy AT lirongyang effectsofneoadjuvantradiotherapyonsurvivalinpatientswithstageiiian2nonsmallcelllungcancerfollowingpneumonectomy AT hanjingyi effectsofneoadjuvantradiotherapyonsurvivalinpatientswithstageiiian2nonsmallcelllungcancerfollowingpneumonectomy AT yueweiming effectsofneoadjuvantradiotherapyonsurvivalinpatientswithstageiiian2nonsmallcelllungcancerfollowingpneumonectomy AT tianhui effectsofneoadjuvantradiotherapyonsurvivalinpatientswithstageiiian2nonsmallcelllungcancerfollowingpneumonectomy |